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Abstract
Background:  Gene expression microarray technology permits the analysis of global gene
expression profiles. The amount of sample needed limits the use of small excision biopsies and/or
needle biopsies from human or animal tissues. Linear amplification techniques have been developed
to increase the amount of sample derived cDNA. These amplified samples can be hybridised on
microarrays. However, little information is available whether microarrays based on amplified and
unamplified material yield comparable results.
In the present study we compared microarray data obtained from amplified mRNA derived from
biopsies of rat cardiac left ventricle and non-amplified mRNA derived from the same organ.
Biopsies were linearly amplified to acquire enough material for a microarray experiment. Both
amplified and unamplified samples were hybridized to the Rat Expression Set 230 Array of
Affymetrix.
Results: Analysis of the microarray data showed that unamplified material of two different left
ventricles had 99.6% identical gene expression. Gene expression patterns of two biopsies obtained
from the same parental organ were 96.3% identical. Similarly, gene expression pattern of two
biopsies from dissimilar organs were 92.8% identical to each other.
Twenty-one percent of reporters called present in parental left ventricular tissue disappeared after
amplification in the biopsies. Those reporters were predominantly seen in the low intensity range.
Sequence analysis showed that reporters that disappeared after amplification had a GC-content of
53.7+/-4.0%, while reporters called present in biopsy- and whole LV-samples had an average GC
content of 47.8+/-5.5% (P <0.001). Those reporters were also predicted to form significantly more
(0.76+/-0.07 versus 0.38+/-0.1) and longer (9.4+/-0.3 versus 8.4+/-0.4) hairpins as compared to
representative control reporters present before and after amplification.
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Conclusion: This study establishes that the gene expression profile obtained after amplification of
mRNA of left ventricular biopsies is representative for the whole left ventricle of the rat heart.
However, specific gene transcripts present in parental tissues were undetectable in the minute left
ventricular biopsies. Transcripts that were lost due to the amplification process were not randomly
distributed, but had higher GC-content and hairpins in the sequence and were mainly found in the
lower intensity range which includes many transcription factors from specific signalling pathways.
Background
Gene expression microarrays have become well estab-
lished technology with which the expression of 10,000's
of genes can be measured simultaneously on a single glass
slide. The primary limitation of large-scale gene expres-
sion studies has always been the requirement for relatively
large amounts of input RNA. Reduction of input RNA by
use of an amplification step can greatly expand the possi-
bilities of gene expression studies, towards small biopsies
from small animals like e.g. rodents and even laser cap-
ture micro dissection material. RNA amplification strate-
gies have been reported in the past few years, in which a
T7-based linear in vitro transcription is most commonly
used [1-3]. In general, these studies describe reproducible
results with high correlations between amplified and non-
amplified RNAs derived from a common pool of high-
quality RNA. The importance of high quality of the start-
ing total RNA for amplification is often stressed [4,5].
However, it is well-known that small tissue samples, espe-
cially when derived from organs that have low RNA con-
tents, do not yield high-quality RNA [6]. Therefore, we
examined the applicability of the RNA amplification tech-
nique in very small, possibly lower-quality biopsy-RNA of
left ventricular (LV) rat heart tissue, by evaluating their
gene expression patterns. The biopsies were taken accord-
ing to a newly developed methodology that enables
repeated sampling of cardiac biopsies in rats in-vivo. Gene
array analysis was performed in order to investigate how
the gene expression profiles of the biopsies relate to the
profiles found in their parental LVs.
Results
Evaluation of left ventricular contractility after taking 
biopsies
The taking of small biopsies of LV tissue might affect car-
diac function. To examine this possibility we compared
cardiac contractility in 6 biopsied and 6 sham-operated
rats. The LV biopsy procedure was not associated with
mortality; all rats survived the observation period of 14
days. In addition, the biopsy procedure did not affect car-
diac contractility and relaxation, the two major determi-
nants of cardiac function (Figure 1).
RNA isolation, amplification and pitfalls
Two rats were used for this experiment. From each LV 3
biopsies were taken. We were able to successfully isolate
RNA from 5 out of 6 biopsies (biopsy #2–3 from LV #1;
biopsy #4–6 from LV #2), and from the two parental LV
samples (LV #1 and #2). Figure 2 shows a representative
example of a Bioanalyser Picochip-plot of RNA isolated
from a rat heart biopsy. Each biopsy approximately
Two weeks after surgery, contraction rate (+dP/dt) (a) and  relaxation rate (-dP/dt) (b) of 6 rat hearts from which biop- sies were taken were compared to data obtained from 6  sham-operated rats Figure 1
Two weeks after surgery, contraction rate (+dP/dt) (a) and 
relaxation rate (-dP/dt) (b) of 6 rat hearts from which biop-
sies were taken were compared to data obtained from 6 
sham-operated rats. Data were obtained by direct LV pres-
sure measurements using a micro-tip pressure transducer 
(Millar Instruments, Tx, USA) inserted into the left ventricle. 
Data were obtained at baseline as well as during dobutamine-
stimulated conditions.BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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yielded 100 ng of total RNA showing some degradation of
28S ribosomal RNA. Biopsy #1 failed to yield RNA
because during surgery the needle did not contain cardiac
tissue rather coagulated blood.
We used 30 ng total RNA of each biopsy sample as input
for first round amplification, and the total amplified
cRNA products were directly biotin labelled in a second
standard Affymetrix amplification reaction. Amplification
efficiency was then quantified by OD260. Four out of 5
labelled products contained more than 200 ng cRNA
(ranging from 300 to 750 ng indicating a 1000–2500 fold
amplification), which was sufficient to hybridize on an
Affymetrix GeneChip microarray. Only biopsy #3-cRNA
yield was not sufficient (156 ng). As a result 4 out of 6
biopsies (#2, #4, #5, and #6) plus two parental LVs were
hybridized on Affymetrix GeneChip microarrays. Length
of cRNA ranged from 100 to 5000 base pairs as deter-
mined by Bioanalyser Nanochip.
TEST-3 chips and rat 230A GeneChips
A TEST-3 Affymetrix chip was run for each sample (2
parental LVs and 4 LV biopsies) to assess cRNA quality on
a transcript level, after biotin labelling of parental LVs #1
and #2 starting from 5.8 µg total RNA, and after amplifi-
cation and labelling starting from 30 ng of total RNA of LV
biopsies #2, #4, #5 and #6. Next, the 4 LV biopsy- and the
2 parental LV-cRNAs were hybridized on rat 230 A Gene-
Chips. Biopsy #5 was excluded from further analysis
because of aberrant, low quality control measures on
TEST3 and 230 A chips.
Consequentially, for the determination of gene expres-
sion profiles we obtained expression results from the two
parental LVs and from three LV biopsies (one biopsy of
LV#1 and two biopsies of LV#2)
Real-time PCR analysis indicates amplification efficiency
Quantitative real-time PCR analysis using a high-, a
medium, and a low-abundance gene transcript discrimi-
nated between well- and badly amplified cRNA samples
(Figure 3, panel a to c). In 3 out of 5 samples (biopsy #2,
#4 and #6) it was observed that the number of PCR cycles
needed to detect these 3 gene transcripts decreased after
amplification. This indicates that these gene products
were amplified successfully and confirmed the good qual-
ity of cRNAs, as seen after test chip and full chip analysis.
The relative gene expression ratios between the biopsies
were preserved after amplification. However in biopsy #3,
the three gene transcripts yielded aberrant Ct values after
amplification; their high Ct values indicated that these
genes had not been amplified properly. For the same rea-
son, amplification data from LV biopsy #5 were aberrant
for the low abundance gene COL6a3.
These data are consistent with the results of the gene
microarray experiment, in which only LV biopsies #2, #4
and #6 yielded gene expression data.
Quality of results
In order to assess the quality of our biopsy samples on
microarray, we evaluated the Average Relative Standard
Deviation (ARSD) of the signal values, given by
where:
nPS = number of probe sets
sdi = standard deviation of the signal values in an experi-
mental group for probe set i
 = average signal value in an experimental group for
probe set i
Next to the biopsy group (n = 3) and the heart sample
group (n = 2) of this study, we also looked at another
biopsy study not yet published, consisting of three groups
of rats (n = 4; n = 6 and n = 4) that were evaluated on the
Affymetrix GeneChip® Rat Genome 230 2.0 array. In addi-
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Representative Bioanalyser Picochip plot of RNA isolated  from one biopsy, with a 28S/18S ratio of 1.43 Figure 2
Representative Bioanalyser Picochip plot of RNA isolated 
from one biopsy, with a 28S/18S ratio of 1.43.BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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Quantitative real-time PCR (qPCR) of biopsy RNA before and after amplification using a high (cyclophilin A), medium (ribos- omal protein S9, RPS9) and low (collagen VI alpha 3, COL6a3) abundance transcript Figure 3
Quantitative real-time PCR (qPCR) of biopsy RNA before and after amplification using a high (cyclophilin A), medium (ribos-
omal protein S9, RPS9) and low (collagen VI alpha 3, COL6a3) abundance transcript. Material for the 'before amplification' 
qPCR was obtained from cDNA synthesis from total biopsy RNA; material for the 'after amplification' qPCR was obtained 
from cDNA synthesis from first round cRNA. After amplification, biopsy #3 yielded aberrant Ct values for all 3 genes; biopsy 
#5 only for COL6a3.BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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tion we compared our results with a study by Schweitzer
et al. downloaded from the Gene Expression Omnibus
(GEO) [7]; GEO accession no. GSE2690[8]. Seventy-two
male Sprague-Dawley rats were separated into three
groups having different access to physical exercise. RNA
was used from 12 heart tissue samples per group, the sam-
ples were pooled and applied to four Affymetrix Gene-
Chip® Rat Genome 230 2.0 arrays per group.
We selected probe sets (n = 4256) with a present call on
all 31 arrays. To compensate for the different scanner and
algorithm parameters used, we first took the log values of
the signals, and subsequently performed a quantile nor-
malization [9]. Since the experiments of this study were
done on a 230 A array, we ignored the 230 B part of the
230 2.0 arrays.
As shown in Table 1, the ARSD values of both biopsy stud-
ies are within two standard deviations of the mean ARSD.
Even when the pooled arrays of the Schweitzer study,
which obviously have a smaller ARSD, are included the
ARSD values are within two standard deviations of the
mean ARSD. In addition, if we regard the arrays as vectors
in a 4256 dimensional space, we can calculate distances
between them, e.g. the Euclidean distance as we did in this
case. The average distance between the probesets present
on all the arrays within each experimental group are given
in the rightmost column of Table 1. The average Euclidean
distance in the current study is of the same order as in the
two additional studies: for the biopsy group it is some-
what larger and for the parental hearts it is slightly
smaller.
Amplification results in non-random loss of gene detection
Gene array analysis was performed in order to investigate
how the gene expression profiles of the LV biopsies relate
to the profiles found in their parental LVs. The analysis
firstly showed that parental LV #1 and #2 had 99.6 %
identical gene expression (with fold change less then 2),
indicating, as expected, that there was very little difference
between those two rats. Gene expression patterns of LV
biopsy #4 and #6 that were originally obtained from the
same parental LV (#2), were for 96.3 % identical. Gene
expression pattern of LV biopsy #2 was 92.8 % identical to
the gene expression patterns of LV biopsy #4 and 6, indi-
cating that biopsies obtained from dissimilar LVs yield
comparable gene expression patterns.
To further explore the information yielded by the two
types of samples, we compared gene array characteristics
of parental LVs and LV biopsies (Figure 4a). On average,
76 % of reporters detected in the parental LV samples #1
and #2 were also detected in LV biopsies #2, #4 and #6
(based on present call in Affymetrix Mas5.0 software). We
compared the differential expression of parental LV#1 ver-
sus LV#2 with the differential expression of LV biopsy #2
versus LV biopsy #4 and 6 respectively, with a threshold
level of 2-fold change. Of the reporters with present calls
in both samples, 96 % did not differ between LV biopsy
#2 and LV biopsies #4 and #6 respectively, whereas 4 % of
reporters that were differentially expressed between the
biopsies were not differential between their parental LVs.
Approximately 21 % of the reporters called present in
parental LVs disappeared after amplification of mRNA of
the LV biopsies (false negatives) while 3 % of reporters
called absent in the parental LVs appeared after amplifica-
tion in the LV biopsies (false positives) (Figure 4a). False
negatives were predominantly (99.5% of total) observed
in the low intensity range, which means reporters with sig-
nal less than 3000 in both parental LVs (Figure 4b).
Table 1: Experiment, arrays, ARSD values and average Euclidean distance for the 4256 probe sets present on all arrays and for the 67 
Affymetrix normalization probe sets present on all 31 arrays.
ARSD Average Euclidean 
distance
Study Arrays 4256 sets 67 norm
Amplification (this study) biopsy (n = 3) 0.023 0.018 1.56
heart (n = 2) 0.008 0.006 0.66
Amplification 2 (unpublished) biopsy group1 (n = 4) 0.016 0.013 0.94
biopsy group2 (n = 6) 0.021 0.016 1.22
biopsy group3 (n = 4) 0.021 0.017 1.26
Exercise (Schweitzer et al.) sedentary (n = 4) 0.012 0.010 0.69
moderate ex (n = 4) 0.011 0.008 0.63
runners (n = 4) 0.012 0.011 0.70
weighted average: 0.015 0.012
weighted sd: 0.005 0.004BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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Gene array data analysis Figure 4
Gene array data analysis. (a) Summary of gene array characteristics, as described in the results section "Amplification results in 
non-random loss of gene detection". Low intensity means a signal of less than 3000 on the Affymetrix gene chip. (b) Signal 
intensity plot in which every gene is represented by a square. Signals of parental LVs #1 and #2 are similar, and gene expression 
data of LV biopsy #2 are visualized in the squares as 'not changed' or 'false negatives'. Biopsy reporters predominantly disap-
pear in the lower expression region of their parental LVs, as exemplified by LV biopsy #2. Data on LV biopsy #4 and 6 are sim-
ilar.BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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This detection failure turned out to be significantly
dependent on GC content and hairpin formation (Figure
5). Reporters that disappeared after amplification had a
GC-content of 53.7% ± 4.0, while reporters called present
in LV biopsy- and parental LV-samples had an average GC
content of 47.8% ± 5.5 (P <0.001) (Figure 5a). This was
also true for the reporters that were in the higher expres-
sion ranges (>3000), where false negatives had a GC con-
tent of 53.7% ± 4.2 compared to the 48.3% ± 5.4 for all
reporters. In the lower intensity range (<3000) the differ-
ence in GC content between reporters that disappeared
after amplification and reporters with a present call in
both the parental LVs and LV biopsies is even larger, being
50.5% ± 6.1 and 43.4% ± 6.9 respectively.
Comparison of the detection calls between parental LVs
and LV biopsies showed that the ratio between present
calls (heart/biopsy) and absent calls (heart/biopsy) is
higher than 1 for all GC contents (Figure 6). Figure 6 also
shows that this ratio increases when the GC% of the
reporters increases (with a maximum at GC content
between 60 and 70 %),
The false negatives in the higher expression range were
predicted to form significantly more (0.76 ± 0.07 versus
0.38 ± 0.1 hairpins per gene) and longer hairpins (9.4 ±
0.3 versus 8.4 ± 0.4 basepairs) as compared to representa-
tive control reporters present before and after amplifica-
tion (Figure 5b and 5c). The reporters that were compared
(with an absent or a present call) were taken from the
same region of expression (same signal intensities).
Finally, we were able to relate these lost, mainly low-
intensity, reporters of all three biopsies to 4 specific major
important signalling pathways (Figure 7, Table 2). These
pathways had z-scores greater than 1 in MAPPFinder, and
included the TGF-beta signalling pathway, the G-protein
signalling pathway, the signal transduction pathway of
the SIP receptor, and the glycogen metabolism signalling
pathway. In those pathways at least 29 % of genes
changed. In contrast, false positive reporters never repre-
sented more than 5% of the genes in biological pathways
available for GenMAPP.
Discussion
In order to perform a gene expression study on biopsy-
material, RNA amplification is necessary. Most studies on
RNA amplification and gene expression have until now
focused on the optimization of the amplification protocol
with diluted high-quality RNA [2]. Stenman et al. [10]
proved dilution to be prone to sampling errors because of
stochastic distribution of low-abundance transcripts. In
addition, applications like biopsies and laser capture
material mostly yield RNA that is not of high quality
[6,11]. Therefore, we optimized our protocol in the even-
tual experimental setting, i.e. with undiluted biopsy RNA.
The quality of first-round amplified cRNA is critical for the
subsequent reactions (second-round labelling and array
hybridization) to succeed. Since these reactions are expen-
sive, it is worthy to be able to check cRNA quality before
proceeding. Real-time PCR can serve as a quality control
step of first-round amplification, thereby saving time and
money by preventing labelling and test chip hybridization
of unsuccessfully amplified RNA samples.
To verify the representativeness of the samples used in the
current study comparisons were made with data from an
unpublished study and a study published in GEO. From
this it can be concluded that the quality of the data
obtained from our biopsy studies is not largely different
from other data on unamplified heart RNA.
Although the small biopsies yielded minimally degraded
RNA, we found that the gene expression profiles after
amplification were reliable and representative of the gene
expression profiles identified in the parental left ventricles
of the rat heart. Amplification is known to cause loss of
low-expressed reporters [2]. Our results show that this loss
is not a random process. We found that false negatives sig-
nificantly correlated with two kinds of nucleotide strand
characteristics. Firstly, in contrast to a study by Gomes et
al [4], we found a highly significant correlation with GC
content of gene transcripts. This can be explained by the
higher affinity bonds between nucleotides G and C as
compared to A and T, resulting in difficulties for the DNA
polymerase to come in-between 'high GC'-double
stranded cDNA in order to make new copies [12]. Sec-
ondly, we found that hairpin formation (secondary fold-
ing structures that often result from the presence of
nucleotide repeats) was correlated significantly to gene
loss after mRNA amplification. The sudden hair-pin-kinks
in their templates can cause DNA polymerase enzymes to
fall off or stop during strand synthesis. Both characteristics
will result in sub-optimal amplification of the target
strand.
In addition, we proved in another way that loss of gene
detection was not a random process. The analyzed biop-
sies showed a consistent loss of specific low-abundance
genes belonging to major important signalling pathways,
including the TGF-beta signalling pathway, the G-protein
signalling pathway, the signal transduction pathway of
the SIP receptor, and the glycogen metabolism signalling
pathway.
In summary, reporters lost after amplification of small
biopsy material have specific sequence characteristics and
belong to specific signalling pathways. Although theBMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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Reporters that were not detected after amplification ■  had a significantly higher mRNA GC-content (53.7% ± 4.0 vs. 47.8% ±  5.5, P < 0.001) Figure 5
Reporters that were not detected after amplification ■  had a significantly higher mRNA GC-content (53.7% ± 4.0 vs. 47.8% ± 
5.5, P <0.001) (a), and contained significantly more (b) and longer (c) hairpins as compared to representative control reporters 
present before and after amplification o (0.76 ± 0.07 vs. 0.38 ± 0.10 hairpins per gene resp., P < 0.01; and 9.4 base pairs (bp) ± 
0.3 per hairpin vs. 8.4 bp ± 0.4 resp., P < 0.05. A hairpin must contain 7 or more base pairs. The compared reporters were 
taken from the same region of expression (same signal intensities).BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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observed differences in detection might be the result of
differences in starting material, it is of importance to
know the above described consequences when one has no
alternative to using biopsy material. However, differences
in detection might also be caused by the different label-
ling procedures (reverse transcription with dT-T7 for
parental LVs versus RT with random primers for the biop-
sies).
The inability to detect low-expressed transcripts in limited
amount of RNA can possibly be overcome by hybridizing
all of the labelled cRNA, as suggested by Li et al [2]. When
starting with less than 50 ng of total RNA, hybridizing the
entire labelled product will increase the amount of detect-
able transcripts, especially of those that are less abundant.
Since two biopsies cannot be taken from the same place in
the LV, we expected a potential large variability between
biopsy gene expression profiles, because of regional differ-
ences in gene expression or because biopsies could repre-
sent different cell types. However, the gene expression
results of LV biopsy #4 and 6, taken from parental LV #2,
were 96.3 % identical. Even comparison to LV biopsy #2
taken from another parental LV (LV #1), correlated well
(92.8 %) although a higher variation in gene expression
could be expected. Finally although a considerable exten-
sive amount (21 %) of expression data was lost by the
biopsy amplification protocol, the LV biopsies yielded a
gene expression pattern that was representative of that of
their parental LV for the remaining reporters.
Conclusion
This study demonstrates that it is possible to amplify RNA
obtained from minute biopsies of the rat LV tissue in a
reproducible way. Although LV biopsies have been
described before in larger animals like dog [13] and sheep
[14], our group has first reported on the use of cardiac
biopsies taken from rodents [15]. This new biopsy tech-
nique shows that it is possible to obtain very small mate-
rial from rat hearts in-vivo. This study establishes that the
gene expression profile obtained from minute LV biopsies
is representative for the whole parental LV. However,
compared to whole parental LV material, a significant set
of gene transcripts were undetectable in the minute LV
biopsies. It is notable that the gene transcripts that were
lost due to the amplification process were not randomly
distributed, but rather had specific sequence characteris-
tics and were mainly found in the lower intensity range
and represented specific signalling pathways. Impor-
tantly, these were signalling pathways involved in hyper-
trophy and heart failure, which must be taken into
account in future biopsy-gene array studies on such ani-
mals.
Methods
Microarrays
Affymetrix GeneChip® Rat Expression Array 230A (REA
230A), with primarily probe sets against well annotated
full-length genes was used for the analysis of gene expres-
sion profiles. The array includes a representation of the
RefSeq database sequences. Oligonucleotide probes com-
plementary to each corresponding sequence are synthe-
sized in situ on the arrays. Eleven pairs of oligonucleotide
probes are used to measure the level of transcription of
each sequence represented on the GeneChip Rat Expres-
sion Set 230.
The GeneChip® Test3 is used to determine the quality of a
labelled target prior to its analysis with the GeneChip
expression arrays (REA 230A). This test array contains
probe sets representing a subset of characterized genes
from various organisms and a subset of human and
mouse housekeeping genes.
Animals and samples
Adult 16 weeks old male Wistar rats (body weight 350–
400 g) were purchased from Charles River (Maastricht,
The Netherlands). Experiments were performed according
to the guidelines of the University of Maastricht and were
approved by the institutional animal ethics committee, in
agreement with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996). The animals
were kept on a 12:12-h light-dark cycle in a temperature-
controlled (21 ± 2°C) room. During the experiment ani-
Ratio between present calls (heart/biopsy) and absent calls  (heart/biopsy) calculated for the different GC% Figure 6
Ratio between present calls (heart/biopsy) and absent calls 
(heart/biopsy) calculated for the different GC%. GC% was 
subdivided in groups of 10%. Grey bars indicate the average ( 
± SEM) of the three comparisons between parental LVs and 
LV biopsies; black bars represent the ratio of detection calls 
when the two parental LVs or all three LV biopsies have the 
same detection call.
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average of three ratios P or A in two LVs or three biopsiesBMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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Visualization of low abundance reporters that disappeared after amplification in 1 to 3 LV biopsies (indicated with different  shades of red), as compared to the expression profiles found in the parental LVs with the computer application GenMAPP Figure 7
Visualization of low abundance reporters that disappeared after amplification in 1 to 3 LV biopsies (indicated with different 
shades of red), as compared to the expression profiles found in the parental LVs with the computer application GenMAPP. 
MAPPs with the highest z-scores in GenMAPP are shown; they represent four major signalling pathways.BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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Table 2: List of genes present in parental left ventricles (LVs) but absent in LV biopsies after microarray analysis. The Pathways 
(MAPPs) with the highest z-scores in MAPPFinder are given in column one with the related genes in those pathways which 
disappeared after amplification. Column two gives the Affymetrix Probe IDs of the corresponding genes. In column three the number 
of LV biopsies in which the gene is absent is given. (Three biopsies were used in the experiment so the maximum number is 3).
Pathway/ Gene Probe ID # Biopsies (max = 3)
Glycogen Metabolism (12 genes on array; 8 genes changed; 67 %)
Phosphorylase B kinase alpha, muscle 1369357_at 3
Phosphorylase B kinase gamma, muscle 1387445_at 3
Phosphorylase B kinase gamma, testis/liver 1367788_at 3
PP2A, catalytic beta 1387261_at 3
PP2A, B subunit, R5 epsilon 1387485_a_at 2
Glycogen phosphorylase, muscle 1370982_at 1
Phosphoglucomutase 1369473_at 2
Glycogen Synthase Kinase 3 beta 1370267_at 1
Signal transduction of S1P receptor (17 genes on array; 5 genes changed; 29 %)
AKT2 1368832_at 3
G alpha i 1 1387505_at 3
G alpha i 2 1367844_at 1
ERK-1 1387771_a_at 3
ERK-2 1369078_at 3
G protein signaling pathways (50 genes on array; 17 genes changed; 34 %)
G beta 2 1398863_at 3
G beta T2 1398863_at 3
G gamma 3 1373202_at 3
G gamma 5 1398818_at 2
AC2 1367978_at 1
AC4 1368370_at 2
AC5 1368298_at 3
G alpha o 1 1368879_a_at 2
G alpha i 1 1387505_at 3
G alpha i 2 1367844_at 1
PKA 2 alpha reg 1371059_at 3
G alpha 11 1387822_at 2
Phosphatase 2B Catalytic beta 1387261_at 3
PKC gamma 1369089_at 1
PKC eta 1369830_at 3
G alpha 12 1369278_at 2
P115 RhoGEF 1370002_at 3
TGF Beta Signaling Pathway (40 genes on array; 13 genes changed; 30 %)
Betaglycan 1369219_at 3
TbR-I 1369504_at 3
Activin 1369012_at 2
BMP 1387232_at 1
Smad1 1369174_at 3
Smad5 1369276_at 3
Smad7 1368896_at 2
Smad2 1368214_at 1
ERK1 1387771_a_at 3
NF-Kappa-B 1370968_at 1
JNK2 1368646_at 1
Osteopontin 1367581_a_at 3
SIP1 1368229_at 1BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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mals had ad libitum access to standard food pellets (Ssniff,
Soest, Germany) and water.
Three biopsies of left ventricular (LV) tissue were taken
from 2 rats in order to measure the gene expression profile
of the biopsies and of the complete left ventricular tissue.
Data from the study by Schweitzer et al. [8] were down-
loaded from the Gene Expression Omnibus (GEO) [7];
GEO accession no. GSE2690.
Myocardial biopsies
Fourteen rats were weighed and anesthetized with keta-
mine (Nimatek®, Eurovet, Bladel, The Netherlands, 45
mg/kg i.m.) and xylazine (Xylalin®, Ceva Sante Animale,
Maassluis, The Netherlands, 5 mg/kg s.c.). The thorax was
shaved and the rats were fixed on a surgical table. Body
temperature was monitored with a rectal probe and main-
tained at 37°C using a warming pad and heating lamp. A
plastic tube (PE 205) was placed in the trachea and con-
nected to a volume cycled rodent respirator (model 683,
Harvard Apparatus, South Natick, MA). Positive pressure
respiration was applied at a frequency of 80 strokes/min
and stroke volume of 3.5 ml. The skin was incised
between the 4th and 5th rib on the left side of the thorax.
The underlying pectoral muscles were gently retracted to
get access to the intercostal muscles. Using a small pair of
tweezers and scissors the intercostal muscles were care-
fully cut (without damaging the lungs), about 2 mm lat-
eral from the sternum. The heart was exposed by retracting
the ribs and the pericardium was opened. Biopsies of left
ventricular (LV) tissue were taken from eight rats by press-
ing a custom-made 0.35 mm (diameter) needle gently
into the anterior wall of the heart. The needle was con-
nected to a slowly (150 rpm) rotating handdrill made by
the Instrument Services department of our university and
advanced 1.3 mm into the left ventricular wall. Care was
taken to avoid pressing the needle into the lumen of the
ventricle, because then the biopsy may be lost into the
blood stream. Three biopsies were taken from each LV.
The samples were immediately snap-frozen in liquid
nitrogen. Of two biopsied rats, the hearts were excised
immediately after biopsy-taking and LVs were snap-frozen
in liquid nitrogen, in order to compare gene expression
profiles of biopsies to parental LVs. Six animals were
sham-operated, i.e. the same surgical procedures were per-
formed but without taking of the actual biopsies. In all
rats the chest was closed using 3-0 silk and negative pres-
sure was restored by gently compressing the chest. The
pectoral muscles were placed over the wound and the skin
was closed with 3-0 silk. After recovery of anaesthesia
buprenorphine (Temgesic®, Schering-Plough, UK; 0.2 mg/
kg s.c.) was given as analgesic. The injection of buprenor-
phine was repeated the next day in the morning and
evening hours.
Evaluation of left ventricular contractility
LV contractility of 12 rats (6 biopsied and 6 sham oper-
ated) was evaluated 14 days after the cardiac biopsy or
sham surgery. For this purpose rats were anesthetized with
urethane (1.5 mg/g body weight i.p., Sigma, St Louis,
USA). Body temperature and respiration were controlled
as described above. A 2.0 F high-fidelity catheter tip
micro-manometer (SPR671, Millar Instruments, Hou-
ston, TX) was inserted through the right carotid artery into
the left ventricular cavity. Ventricular pressure was meas-
ured and sampled at a rate of 2 kHz. Maximal positive (+
dP/dt) and negative (-dP/dt) pressure development were
determined on a beat-to-beat basis and one-second aver-
ages were stored on disk. Measurements were performed
in baseline conditions and during maximal adrenergic
stimulation of the heart. This was achieved by an i.v.
ramp-infusion of dobutamine (1.5 to 15 µg/kg.min,
Sigma) using a microinjection pump (Model 200 Series,
KdScientific, Boston, MA). In this protocol the infusion
rate of the dobutamine solution (50 µg/ml) was increased
every 2 minutes by 20 µl/min up to 100 µl/min and max-
imum values in the last 30 seconds of each period were
determined.
RNA isolation
LV biopsies (biopsy#1–6) and their respective LVs (paren-
tal LV #1 and #2) were snap frozen in liquid nitrogen
before RNA isolation. The two parental LVs were homog-
enized with a rotor-stator and total RNA was isolated
using the RNeasy Mini kit (Qiagen, Valencia, CA), follow-
ing manufacturer's instructions. Total RNA was isolated
from 6 biopsies with the PicoPure® RNA Isolation Kit (Arc-
turus, Mountain View, CA), according to manufacturer's
instructions. Briefly, the frozen biopsy was added to the
RNA extraction buffer using a pipette-tip and immediately
lysed by pipetting up and down. Then, the lysate was
heated at 42°C for 30 minutes, precipitated with 70% eth-
anol, transferred to a pre-conditioned silica membrane
column, and DNA and proteins were removed by a series
of wash and elution steps. Total RNA was eluted in 11 µl
elution buffer.
The quality of the RNA samples was measured in a 2100
Bioanalyser (Agilent Technologies, Amstelveen, The Neth-
erlands) using the Eukaryote Total RNA Nano and Pico
assay, respectively. Total RNA quantity was determined by
the NanoDrop®  ND-1000 UV-Vis Spectrophotometer
(Nanodrop technologies, Rockland, USA).
RNA amplification
Total RNA isolated from the LV biopsies was amplified for
a second round using a protocol largely based on the lin-
ear T7-based procedure described by Baugh [16], with
some minor modifications, and thereby resembles the
current Affymetrix protocol for first round RNA amplifica-BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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tion (GeneChip® Two-Cycle cDNA Synthesis, round 1).
We used 30 ng of total biopsy RNA in a reverse transcrip-
tion reaction with 50 pmol oligo(dT)-T7 promotor primer
(5'-GGCCAGTGAATTGTAATACGACTCACTATAGGGAG-
GCGG-(dT)24 3'; Affymetrix, Inc., Santa Clara, CA) for first
strand cDNA synthesis. For second-strand synthesis, first-
strand mRNA fractions cleaved by RNase H served as
primers, after which the double-stranded cDNA was puri-
fied by phenol:chloroform:isoamyl extraction. In vitro
transcription was then mediated by T7 polymerase activity
(Ambion, Austin, TX) on the incorporated T7 promotor.
The synthesized antisense RNA (aRNA) was purified using
RNeasy mini columns (Qiagen, Valencia, CA) and then
quantified using the NanoDrop® ND-1000 UV-Vis Spec-
trophotometer (Nanodrop technologies, Rockland, USA).
Reverse transcription and real-time quantitative analysis 
of total RNA and one round- aRNA
Sixty ng of biopsy total RNA and first round-aRNA were
reverse transcribed to single-stranded cDNA using 0.5 µg
random primers and 100 U Superscript II reverse tran-
scriptase (Invitrogen, Life Technologies, Breda, The Neth-
erlands). Real-time quantitative PCR was performed using
Taqman primers and probes designed with Primer Express
Software (PE Applied Biosystems, Foster City, CA) (Table
3). We designed exon spanning probes to prevent ampli-
fication of possibly contaminating rat genomic DNA. A
high-, medium-, and low-abundance transcript was
selected in order to address quality and quantity of the
RNA.
Optimal PCR conditions were found to be 12.5 µl 2 × PCR
Master Mix for Taqman™ assays, with a final concentra-
tion of 5 mM MgCl2, 300 nM of each primer, 200 nM
probe, and 10 ng cDNA-template in a total volume of 25
µl. Amplification and detection were carried out using the
ABI Prism 7700 Sequence Detection System (PE Applied
Biosystems).
RNA labelling and hybridization
First round biopsy-aRNA (200 ng) and heart-total RNA
(5.8 µg) were biotin-labeled in a separate amplification
round. For first strand cDNA synthesis, random primers
were used in case of aRNA and oligo(dT)-T7 promotor
primers were used in case of total RNA. Second strand
cDNA synthesis and biotin-labelling by in vitro transcrip-
tion were performed following GeneChip® Eukaryotic tar-
get labelling assay as instructed by Affymetrix. Length of
the labelled cRNA products was assessed by Eukaryote
mRNA Nano assay in a 2100 Bioanalyser (Agilent Tech-
nologies, Palo Alto, CA, USA). Then 12 µg of the labelled
copy RNA (cRNA) products were fragmented following
Affymetrix instructions. The fragmented cRNA products
were firstly hybridized to GeneChip Test3 gene arrays to
assess cRNA quality, and then to Rat Expression Set 230 A
(REA230A) GeneChip arrays (Affymetrix), for 16 hours at
45°C following standard Affymetrix protocol.
Image and data analysis
The gene arrays were scanned by using a Hewlett Packard
Genearray Scanner (Hewlett -Packard, Palo Alto, Califor-
nia, USA) using identical parameters for all slides.
From data image files, gene transcript levels were deter-
mined with the use of algorithms in the Microarray Anal-
ysis Suite Software version 5.0 (MAS 5.0) (Affymetrix).
Global Scaling was performed by setting the average sig-
nal intensity of each array to a Target Signal of 500. Since
the data were scaled, normalization was not necessary and
the normalization value was set to 1.0. From each gene
Table 3: Sequences of real-time quantitative RT-PCR primers and probes of high-, medium- and low-abundance gene transcripts in 
rats
Gene Primer Sequence (5'→3') Position
Cyclophilin A (M19533) (high) F GGGAGAAAGGATTTGGCTATAAGG 167–190
Probe TGAAGTCACCACCCTGGCACATGAAT 219–244
R GCCACCAGTGCCATTATGG 249–267
Ribosomal Protein S9 (NM_031108) (medium) F CTCGACCAGGAGCTAAAGTTGATT 99–122
Probe ACACCTCACGTTTGTTCCGGAGTCCATACT 127–156
R TCTTCGCCAGGGTAAATTTGA 163–183
Collagen VI alpha 3 (XM_346073) (low) F CAGGAGGACCGAGAGCTCAT 7630–7649
Probe ATGCCTTGCAGATCAATAACACAGCAGTAGG 7652–7682
R CCCTCCTTGCAGGCAGAAC 7693–7711
The probes were labelled at the 5' and 3' positions with 6-carboxyfluorescein reporter and 6-carboxytetramethylrhodamine quencher, respectively. 
The position of the primers and probes were annotated according to the sequences derived from GenBank (accession numbers given in 
parenthesis). F, forward; R, reverse.BMC Bioinformatics 2006, 7:200 http://www.biomedcentral.com/1471-2105/7/200
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array a chip file was created that contained the output
from the analysis (signal, detection call and detection p-
value).
Expression profiles from two GeneChip gene arrays were
compared as follows: one array was designated as the
baseline array and another as the experimental array. A
comparison chip file was created with the output of the
comparison (signal log ratio, change call and change p-
value). To determine the most significant changed tran-
scripts a "robust change" analysis was performed which
included the metrics detection (present), change (increase
or decrease) and signal ratio (1.0 or -1.0).
The chip files were transformed into Excel files and loaded
into Spotfire Decision Site (Somerville, MA, USA) to visu-
alize the results of the MAS 5.0 software.
Publication of microarray data
The gene array data are publicly available in the ArrayEx-
press database at the European Bioinformatics Institute
(EBI) (Accession number: E-AFMX-10).
Sequence feature analysis
We studied selected structural features of the consensus
sequences of the probe sets that were present on the gene
array of the parental LVs but absent on the gene array of
the amplified LV biopsy-samples. The GC content of all
reporters present in both heart-samples was calculated in
an automated way as a percentage of the total nucleotides
present in the RefSeq sequence (as was used for probe set
design) [17] using a custom-made script [18]. The GC
content of reporters not detected after amplification was
compared to the GC content of reporters present before
(whole heart) and after (biopsy) amplification. Hairpin
formation of selected disappeared reporters (from the
higher intensity range (>3000) and representative con-
trols taken from the same signal intensity region was
assessed manually by the program DNAMAN version 4.0
(Lynnon Corporation, Quebec, Canada) and number and
length of hairpins were calculated per consensus sequence
on the GeneChip.
Identification of biological processes in array data
To identify biological processes affected by the RNA
amplification, the visualisation tool GenMAPP (Gene
Map Annotator and Pathway Profiler) version 2.0 [19]
was used. This is a generally accessible program for view-
ing and analyzing gene array data on microarray pathway
profiles (MAPPs) representing biological pathways or any
other functional grouping of genes [20]. We used all rat
MAPPs generated from the Gene Ontology database
[21,22], and in addition we used local rat MAPPS gener-
ated from the G-protein Coupled Receptor Database
[23,24], the KEGG database [25-27] and MAPPs specifi-
cally designed for GenMAPP. We imported the gene
expression data into the program and dynamically linked
them to the MAPPs with a tool called MAPPFinder, that
calculates the percentage of genes that meet a user-defined
criterion and a z-score [28]. The z-score is a standardized
difference-score using expected value and standard devia-
tion of the number of genes meeting the criterion on a
MAPP, taking into account MAPP sizes, and it is a measure
for differential gene expression.
Statistical analyses
All data are presented as mean ± standard deviation. Sig-
nificance was accepted at P <0.05. Analyses were per-
formed using the statistical package SPSS 10.0 (Chicago,
IL, USA), employing student's t-test and Mann-Whitney
test.
In addition Average Relative Standard Deviations (ARSD)
on arrays and Euclidean distances between arrays were
calculated using dedicated tools written in C++. Tools are
available on the BiGCaT Bioinformatics Tools database
[18].
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